Imara: Potential Liquidation


  • Imara has announced strategic alternatives and has announced the sale its key asset.
  • It now trades 37% below its Pro Forma net cash levels and a liquidation would be ideal.
  • The main risk here is management pursuing a reverse-merger.
  • Looking for a helping hand in the market? Members of Special Situation Investing get exclusive ideas and guidance to navigate any climate. Learn More »
Walking direction on asphalt

stockarm/iStock via Getty Images

Imara (IMRA) is a failed $60m MCAP biotech company trading at a 37% discount to its Pro Forma net cash levels. In April, the company reduced its workforce by around 83% (to a total of 6 employees), discontinued its treatment development pipeline (relating

Highest conviction ideas for Premium subscribers first

Thanks for reading my article. Make sure to also check out my premium service - Special Situation Investing. Now is a perfect time to join - with today's high equity market volatility, there is an abundance of lucrative event-driven opportunities to capitalize on. So far our strategy has generated 30-50% returns annually. We expect the same going forward.

I launched the service recently and there is a special $100 OFF till the end of September.

SIGN UP NOW and receive instant access to my highest conviction investment ideas + premium weekly newsletter.

This article was written by

Dalius Taurus profile picture
High conviction event-driven investments. Actionable and catalyst rich.

Focused on event-driven trades and special situations. Always looking for an edge.  

The last 10 years of my life have been devoted to the investment world, with event-driven opportunities being my bread and butter. I was and still am surprised by the extent the markets are mis-pricing the risks/rewards in some situations - markets are very far from being efficient and your own research can give you a very sizable edge.

I have considerable professional experience in investment banking and strategy consulting, as well as a number of finance degrees under my belt. My entrepreneurial spirit has also enabled me to launch a number of new businesses, some of which have succeeded and some of which have failed. I am lucky enough to have skills in both business development and investment analysis - this is a winning combination that allows me to quickly recognize and filter out the most attractive investment opportunities in the market.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (13)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.